299 results
Page 3 of 15
S-8
EX-5.1
5e9q11jl47m tsrc
28 Jun 23
Registration of securities for employees
6:35am
S-8
EX-99.2
konjo2yb fwnc4m
28 Jun 23
Registration of securities for employees
6:35am
S-8
m33lsuays3b09y4dc80
28 Jun 23
Registration of securities for employees
6:35am
6-K
63yy5a4b9k8 ty
28 Jun 23
Current report (foreign)
6:02am
6-K
EX-99.1
2sfcz7ba
23 Jun 23
Current report (foreign)
6:13am
6-K
2f4hb8
9 Jun 23
Current report (foreign)
6:03am
6-K
0tsppgcafr6 j17
1 Jun 23
Current report (foreign)
6:02am
6-K
EX-99.1
dgi wjyn7xl
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
sb18gb 6dz0bvue5
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
u6caw6jrjh7goeh
30 May 23
Current report (foreign)
6:11am
6-K
5sfo6gmjb bwt
17 May 23
Current report (foreign)
6:02am
6-K
0rbr698aa oh
11 May 23
Current report (foreign)
6:10am
6-K
y0c 23r8ej
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
v0unlclo2bc5662tu
11 May 23
Current report (foreign)
6:07am
6-K
gdsh2b
30 Mar 23
Current report (foreign)
6:19am
6-K
7td3l5yw
21 Dec 22
Current report (foreign)
6:01am
6-K
EX-99.1
v3frrmd59hr
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am